Tracking sex-dependent differences in a mouse model of CLN6-Batten disease

被引:12
|
作者
Poppens, McKayla J. [1 ]
Cain, Jacob T. [1 ]
Johnson, Tyler B. [1 ]
White, Katherine A. [1 ]
Davis, Samantha S. [1 ]
Laufmann, Rachel [1 ]
Kloth, Alexander D. [2 ]
Weimer, Jill M. [1 ,3 ]
机构
[1] Sanford Res, Pediat & Rare Dis Grp, Sioux Falls, SD 57104 USA
[2] Augustana Univ, Dept Biol, Sioux Falls, SD USA
[3] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57186 USA
关键词
Neuronal ceroid lipofuscinoses; Rare disease; Lysosomal storage disorder; Neurodegenerative disease; Pediatric disease; NEURONAL CEROID-LIPOFUSCINOSIS; BATTEN-DISEASE; COGNITIVE IMPAIRMENT; MUTATIONS; SPECTRUM; ESTROGEN; MICROGLIA; DISORDER; GENE;
D O I
10.1186/s13023-019-0994-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CLN6-Batten disease is a rare neurodevelopmental disorder characterized pathologically by the accumulation of lysosomal storage material, glial activation and neurodegeneration, and phenotypically by loss of vision, motor coordination, and cognitive ability, with premature death occurring in the second decade of life. In this study, we investigate whether sex differences in a mouse model of CLN6-Batten disease impact disease onset and progression. A number of noteworthy differences were observed including elevated accumulation of mitochondrial ATP synthase subunit C in the thalamus and cortex of female Cln6 mutant mice at 2 months of age. Moreover, female mutant mice showed more severe behavioral deficits. Beginning at 9 months of age, female mice demonstrated learning and memory deficits and suffered a more severe decline in motor coordination. Further, compared to their male counterparts, female animals succumbed to the disease at a slightly younger age, indicating an accelerated disease progression. Conversely, males showed a marked increase in microglial activation at 6 months of age in the cortex relative to females. Thus, as female Cln6 mutant mice exhibit cellular and behavioral deficits that precede similar pathologies in male mutant mice, our findings suggest the need for consideration of sex-based differences in CLN6 disease progression during development of preclinical and clinical studies.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Tracking sex-dependent differences in a mouse model of CLN6-Batten disease
    McKayla J. Poppens
    Jacob T. Cain
    Tyler B. Johnson
    Katherine A. White
    Samantha S. Davis
    Rachel Laufmann
    Alexander D. Kloth
    Jill M. Weimer
    Orphanet Journal of Rare Diseases, 14
  • [2] Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease
    Cain, Jacob T.
    Likhite, Shibi
    White, Katherine A.
    Timm, Derek J.
    Davis, Samantha S.
    Johnson, Tyler B.
    Dennys-Rivers, Cassandra N.
    Rinaldi, Federica
    Motti, Dario
    Corcoran, Sarah
    Morales, Pablo
    Pierson, Christopher
    Hughes, Stephanie M.
    Lee, Stella Y.
    Kaspar, Brian K.
    Meyer, Kathrin
    Weimer, Jill M.
    MOLECULAR THERAPY, 2019, 27 (10) : 1836 - 1847
  • [3] Sex-Dependent Differences in Amyloid-β Deposition in a Mouse Model of Alzheimer's Disease
    Gee, Michael
    Thai, Stephenie
    Pires, Paulo
    FASEB JOURNAL, 2021, 35
  • [4] Sex-Dependent Differences in a Mouse Model of Acta2-Related Cerebrovascular Disease
    Wright, Jamie M.
    Chen, Jiyuan
    Milewicz, Dianna M.
    STROKE, 2017, 48
  • [5] Sex-Dependent Synaptic Alterations in a Mouse Model of Alzheimer's Disease
    Dugan, Brittany J.
    Dockery, Myles
    JOURNAL OF NEUROSCIENCE, 2024, 44 (36):
  • [6] Longitudinal characterization of the Cln8mnd mouse model of CLN8 Batten Disease.
    Cerrada-Gimenez, Marc
    Kalesnykas, Giedrius
    Lehtimaki, Kimmo
    Bragge, Timmo
    Puolivali, Jukka
    Rytkonen, Jussi
    Poutiainen, Pekka
    Johnson, Tyler
    Cain, Jacob
    Davis, Samantha
    Nurmi, Antti
    Weimer, Jill
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] Prevention of Photoreceptor Cell Loss in a Cln6nclf Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells
    Holthaus, Sophia-Martha Kleine
    Ribeiro, Joana
    Abelleira-Hervas, Laura
    Pearson, Rachael A.
    Duran, Yanai
    Georgiadis, Anastasios
    Sampson, Robert D.
    Rizzi, Matteo
    Hoke, Justin
    Maswood, Ryea
    Azam, Selina
    Luhmann, Ulrich F. O.
    Smith, Alexander J.
    Mole, Sara E.
    Ali, Robin R.
    MOLECULAR THERAPY, 2018, 26 (05) : 1343 - 1353
  • [8] Targeted disruption of the Cln3 gene provides a mouse model for Batten disease
    Mitchison, HM
    Bernard, DJ
    Greene, NDE
    Cooper, JD
    Junaid, MA
    Pullarkat, RK
    de Vos, N
    Breuning, MH
    Owens, JW
    Mobley, WC
    Gardiner, RM
    Lake, BD
    Taschner, PEM
    Nussbaum, RL
    NEUROBIOLOGY OF DISEASE, 1999, 6 (05) : 321 - 334
  • [9] Searching for novel biomarkers using a mouse model of CLN3-Batten disease
    Timm, Derek
    Cain, Jacob T.
    Geraets, Ryan D.
    White, Katherine A.
    Koh, Seung Yon
    Kielian, Tammy
    Pearce, David A.
    Hastings, Michelle L.
    Weimer, Jill M.
    PLOS ONE, 2018, 13 (08):
  • [10] Retinal preservation following lateral ventricle injection of AAV9-Cln6 into mouse model for Batten disease
    Lu, Bin
    Meyerink, B.
    White, K. A.
    Weimer, J. M.
    Svendsen, C. N.
    Wang, Shaomei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)